429 related articles for article (PubMed ID: 17761653)
1. Molecular mechanisms of spinal muscular atrophy.
Sumner CJ
J Child Neurol; 2007 Aug; 22(8):979-89. PubMed ID: 17761653
[TBL] [Abstract][Full Text] [Related]
2. Spinal muscular atrophy diagnostics.
Prior TW
J Child Neurol; 2007 Aug; 22(8):952-6. PubMed ID: 17761649
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy.
Thurmond J; Butchbach ME; Palomo M; Pease B; Rao M; Bedell L; Keyvan M; Pai G; Mishra R; Haraldsson M; Andresson T; Bragason G; Thosteinsdottir M; Bjornsson JM; Coovert DD; Burghes AH; Gurney ME; Singh J
J Med Chem; 2008 Feb; 51(3):449-69. PubMed ID: 18205293
[TBL] [Abstract][Full Text] [Related]
4. Molecular and functional analysis of intragenic SMN1 mutations in patients with spinal muscular atrophy.
Sun Y; Grimmler M; Schwarzer V; Schoenen F; Fischer U; Wirth B
Hum Mutat; 2005 Jan; 25(1):64-71. PubMed ID: 15580564
[TBL] [Abstract][Full Text] [Related]
5. Clinical trials in spinal muscular atrophy.
Darras BT; Kang PB
Curr Opin Pediatr; 2007 Dec; 19(6):675-9. PubMed ID: 18025935
[TBL] [Abstract][Full Text] [Related]
6. SMN genotypes producing less SMN protein increase susceptibility to and severity of sporadic ALS.
Veldink JH; Kalmijn S; Van der Hout AH; Lemmink HH; Groeneveld GJ; Lummen C; Scheffer H; Wokke JH; Van den Berg LH
Neurology; 2005 Sep; 65(6):820-5. PubMed ID: 16093455
[TBL] [Abstract][Full Text] [Related]
7. Spinal muscular atrophy: from gene to therapy.
Wirth B; Brichta L; Hahnen E
Semin Pediatr Neurol; 2006 Jun; 13(2):121-31. PubMed ID: 17027862
[TBL] [Abstract][Full Text] [Related]
8. Identification of a battery of tests for drug candidate evaluation in the SMNDelta7 neonate model of spinal muscular atrophy.
El-Khodor BF; Edgar N; Chen A; Winberg ML; Joyce C; Brunner D; Suárez-Fariñas M; Heyes MP
Exp Neurol; 2008 Jul; 212(1):29-43. PubMed ID: 18455159
[TBL] [Abstract][Full Text] [Related]
9. Animal models of spinal muscular atrophy.
Schmid A; DiDonato CJ
J Child Neurol; 2007 Aug; 22(8):1004-12. PubMed ID: 17761656
[TBL] [Abstract][Full Text] [Related]
10. Therapeutics development for spinal muscular atrophy.
Sumner CJ
NeuroRx; 2006 Apr; 3(2):235-45. PubMed ID: 16554261
[TBL] [Abstract][Full Text] [Related]
11. Hydroxyurea enhances SMN2 gene expression in spinal muscular atrophy cells.
Grzeschik SM; Ganta M; Prior TW; Heavlin WD; Wang CH
Ann Neurol; 2005 Aug; 58(2):194-202. PubMed ID: 16049920
[TBL] [Abstract][Full Text] [Related]
12. Genetic conversion of an SMN2 gene to SMN1: a novel approach to the treatment of spinal muscular atrophy.
DiMatteo D; Callahan S; Kmiec EB
Exp Cell Res; 2008 Feb; 314(4):878-86. PubMed ID: 18078930
[TBL] [Abstract][Full Text] [Related]
13. Spinal muscular atrophy: molecular genetics and diagnostics.
Ogino S; Wilson RB
Expert Rev Mol Diagn; 2004 Jan; 4(1):15-29. PubMed ID: 14711346
[TBL] [Abstract][Full Text] [Related]
14. An intronic element contributes to splicing repression in spinal muscular atrophy.
Kashima T; Rao N; Manley JL
Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3426-31. PubMed ID: 17307868
[TBL] [Abstract][Full Text] [Related]
15. Salbutamol increases SMN mRNA and protein levels in spinal muscular atrophy cells.
Angelozzi C; Borgo F; Tiziano FD; Martella A; Neri G; Brahe C
J Med Genet; 2008 Jan; 45(1):29-31. PubMed ID: 17932121
[TBL] [Abstract][Full Text] [Related]
16. Stimulating full-length SMN2 expression by delivering bifunctional RNAs via a viral vector.
Baughan T; Shababi M; Coady TH; Dickson AM; Tullis GE; Lorson CL
Mol Ther; 2006 Jul; 14(1):54-62. PubMed ID: 16580882
[TBL] [Abstract][Full Text] [Related]
17. Fishing for a mechanism: using zebrafish to understand spinal muscular atrophy.
Beattie CE; Carrel TL; McWhorter ML
J Child Neurol; 2007 Aug; 22(8):995-1003. PubMed ID: 17761655
[TBL] [Abstract][Full Text] [Related]
18. Molecular functions of the SMN complex.
Kolb SJ; Battle DJ; Dreyfuss G
J Child Neurol; 2007 Aug; 22(8):990-4. PubMed ID: 17761654
[TBL] [Abstract][Full Text] [Related]
19. Death of motoneurons induced by trophic deprivation or by excitotoxicity is not prevented by overexpression of SMN.
Cisterni C; Kallenbach S; Jordier F; Bagnis C; Pettmann B
Neurobiol Dis; 2001 Apr; 8(2):240-51. PubMed ID: 11300720
[TBL] [Abstract][Full Text] [Related]
20. Valproic acid increases SMN levels in spinal muscular atrophy patient cells.
Sumner CJ; Huynh TN; Markowitz JA; Perhac JS; Hill B; Coovert DD; Schussler K; Chen X; Jarecki J; Burghes AH; Taylor JP; Fischbeck KH
Ann Neurol; 2003 Nov; 54(5):647-54. PubMed ID: 14595654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
